de Jong JW - Search Results

1

Effect of acadesine on myocardial ischaemia in patients with coronary artery disease.

de Jonge R, Macleod DC, Suryapranata H, van Es GA, Friedman J, Serruys PW, de Jong JW. de Jonge R, et al. Among authors: de jong jw. Eur J Pharmacol. 1997 Oct 15;337(1):41-4. doi: 10.1016/s0014-2999(97)01239-9. Eur J Pharmacol. 1997. PMID: 9389379 Clinical Trial.

2

Preconditioning of rat hearts by adenosine A1 or A3 receptor activation.

De Jonge R, Out M, Maas WJ, De Jong JW. De Jonge R, et al. Among authors: de jong jw. Eur J Pharmacol. 2002 Apr 26;441(3):165-72. doi: 10.1016/s0014-2999(01)01611-9. Eur J Pharmacol. 2002. PMID: 12063088

3

Myocardial protection by intravenous diltiazem during angioplasty of single-vessel coronary artery disease.

Bonnier JJ, Huizer T, Troquay R, van Es GA, de Jong JW. Bonnier JJ, et al. Among authors: de jong jw. Am J Cardiol. 1990 Jul 15;66(2):145-50. doi: 10.1016/0002-9149(90)90578-o. Am J Cardiol. 1990. PMID: 2196772 Clinical Trial.

4

Myocardial release of hypoxanthine and lactate during percutaneous transluminal coronary angioplasty.

Serruys PW, Suryapranata H, Piscione F, Harmsen E, van den Brand M, de Feyter P, Hugenholtz PG, de Jong JW. Serruys PW, et al. Among authors: de feyter p, de jong jw. Am J Cardiol. 1989 Mar 7;63(10):45E-51E. doi: 10.1016/0002-9149(89)90230-0. Am J Cardiol. 1989. PMID: 2522269 Free article.

5

Ischemic preconditioning--do we need more (pharmacological) experiments?

de Jong JW, de Jonge R. de Jong JW, et al. Among authors: de jonge r. Basic Res Cardiol. 1997;92 Suppl 2:48-50. Basic Res Cardiol. 1997. PMID: 9457373 Review. No abstract available.

6

Ischemic preconditioning and glucose metabolism during low-flow ischemia: role of the adenosine A1 receptor.

de Jonge R, de Jong JW. de Jonge R, et al. Among authors: de jong jw. Cardiovasc Res. 1999 Sep;43(4):909-18. doi: 10.1016/s0008-6363(99)00137-6. Cardiovasc Res. 1999. PMID: 10615418

7

Role of adenosine and glycogen in ischemic preconditioning of rat hearts.

de Jonge R, de Jong JW, Giacometti D, Bradamante S. de Jonge R, et al. Among authors: de jong jw. Eur J Pharmacol. 2001 Feb 23;414(1):55-62. doi: 10.1016/s0014-2999(00)00875-x. Eur J Pharmacol. 2001. PMID: 11230995

8

Cardioprotection by ischemic preconditioning. Role of adenosine and glycogen.

de Jonge R, Bradamante S, de Jong JW. de Jonge R, et al. Among authors: de jong jw. Adv Exp Med Biol. 1998;431:279-82. Adv Exp Med Biol. 1998. PMID: 9598075 Review. No abstract available.

9

The role of adenosine in preconditioning.

de Jong JW, de Jonge R, Keijzer E, Bradamante S. de Jong JW, et al. Among authors: de jonge r. Pharmacol Ther. 2000 Aug-Sep;87(2-3):141-9. doi: 10.1016/s0163-7258(00)00044-9. Pharmacol Ther. 2000. PMID: 11007996 Review.

10

Nifedipine for angina and acute myocardial ischaemia.

Hugenholtz PG, Verdouw PD, de Jong JW, Serruys PW. Hugenholtz PG, et al. Among authors: de jong jw. Postgrad Med J. 1983;59 Suppl 2:40-58. Postgrad Med J. 1983. PMID: 6351043 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page